Literature DB >> 20523775

Osteoma cutis as the presenting feature of albright hereditary osteodystrophy associated with pseudopseudohypoparathyroidism.

Ki-Heon Jeong1, Bark-Lynn Lew, Woo-Young Sim.   

Abstract

Primary osteoma cutis is characterized by the formation of normal bone tissue in the dermis or subcutis without any underlying tissue abnormality or pre-existing calcification. This illness is associated with Albright hereditary osteodystrophy (AHO), which is characterized by such physical features as a short stature, round face, obesity, brachydactyly and osteoma cutis. Pseudohypoparathyroidism (PHP) is an inherited metabolic disorder that's characterized by resistance to parathyroid hormone, and PHP is present in most AHO patients. An AHO phenotype without hormonal resistance is called pseudopseudohypoparathyroidism (PPHP). Osteoma cutis is less common in patients with PPHP than in patients with PHP. We present here a case of osteoma cutis as the cardinal manifestation of AHO associated with PPHP. Osteoma cutis is an important sign of AHO and its significance should not be overlooked, even if the patient has normal values on the serum biochemical tests.

Entities:  

Keywords:  Albright hereditary osteodystrophy; Osteoma cutis; Pseudohypoparathyroidism; Pseudopseudohypoparathyroidism

Year:  2009        PMID: 20523775      PMCID: PMC2861203          DOI: 10.5021/ad.2009.21.2.154

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN: 1013-9087            Impact factor:   1.444


  13 in total

1.  Cutaneous ossification. Report of 120 cases and review of the literature.

Authors:  S I ROTH; R E STOWELL
Journal:  Arch Pathol       Date:  1963-07

2.  Osteoma cutis as a presenting sign of pseudohypoparathyroidism.

Authors:  J S Prendiville; A W Lucky; S B Mallory; Z Mughal; F Mimouni; C B Langman
Journal:  Pediatr Dermatol       Date:  1992-03       Impact factor: 1.588

3.  Cutaneous ossification in Albright's hereditary osteodystrophy.

Authors:  R M Trüeb; R G Panizzon; G Burg
Journal:  Dermatology       Date:  1993       Impact factor: 5.366

4.  Reduction in Gsalpha induces osteogenic differentiation in human mesenchymal stem cells.

Authors:  Steven A Lietman; Changlin Ding; David W Cooke; Michael A Levine
Journal:  Clin Orthop Relat Res       Date:  2005-05       Impact factor: 4.176

5.  Progressive osseous heteroplasia-like heterotopic ossification in a male infant with pseudohypoparathyroidism type Ia: a case report.

Authors:  Inessa M Gelfand; Rachel S Hub; Eileen M Shore; Frederick S Kaplan; Linda A Dimeglio
Journal:  Bone       Date:  2006-12-28       Impact factor: 4.398

6.  Body mass index differences in pseudohypoparathyroidism type 1a versus pseudopseudohypoparathyroidism may implicate paternal imprinting of Galpha(s) in the development of human obesity.

Authors:  Dominique N Long; Sarah McGuire; Michael A Levine; Lee S Weinstein; Emily L Germain-Lee
Journal:  J Clin Endocrinol Metab       Date:  2006-12-12       Impact factor: 5.958

7.  Osteoma cutis in pseudohypoparathyroidism.

Authors:  G Sethuraman; A K Malhotra; B K Khaitan; R Kumar; V K Sharma; M Kabra; M K Singh
Journal:  Clin Exp Dermatol       Date:  2006-03       Impact factor: 3.470

8.  Idiopathic multiple miliary osteomas of the face.

Authors:  C Novak; G Siller; D Wood
Journal:  Australas J Dermatol       Date:  1998-05       Impact factor: 2.875

9.  Albright's hereditary osteodystrophy.

Authors:  Seema Kapoor; Siddhartha Gogia; Ritu Paul; Sharmila Banerjee
Journal:  Indian J Pediatr       Date:  2006-02       Impact factor: 1.967

10.  Metabolic bone disease in pseudohypoparathyroidism: radiologic features.

Authors:  M I Burnstein; S R Kottamasu; J M Pettifor; E Sochett; B I Ellis; B Frame
Journal:  Radiology       Date:  1985-05       Impact factor: 11.105

View more
  3 in total

Review 1.  [Syndroms associated with benign skin tumors].

Authors:  George-Sorin Tiplica; Klaus Fritz; Alexandra Irina Butacu; Loredana Ungureanu; Carmen Maria Sălăvăstru
Journal:  Hautarzt       Date:  2022-01-25       Impact factor: 0.751

2.  Two cases of treatment with aromatase inhibitors and development of miliary osteoma cutis-Is there an association?

Authors:  Eric D Schadler; Stephanie L Mehlis; Thomas L Cibull; Bernhard Ortel
Journal:  JAAD Case Rep       Date:  2018-08-01

3.  Basal Cell Carcinoma with Osteoma Cutis.

Authors:  Stella X Chen; Philip R Cohen
Journal:  Cureus       Date:  2018-08-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.